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A B S T R A C T
We present a case of dengue myocarditis related Mobitz type I atrio-ventricular (A-V) block. To our
knowledge, this is the ﬁrst report of such a patient requiring pacing. An early response to
methylprednisolone suggests the possibility of a therapeutic role for steroids in these patients.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The arbovirus dengue is an important cause of morbidity and
mortality in tropical countries. The most common cardiac
manifestation of dengue viral infection is myocarditis [1].
Abnormalities of cardiac rhythm are a recognized complication
of myocarditis and have been reported in association with dengue
cardiac involvement [1]. A-V blocks are, however, a rare
complication of dengue myocarditis. We report a case of Mobitz
type I A-V block in a patient with dengue myocarditis who required
transvenous pacing for symptomatic bradycardia.
Case report
A 20 year old Sri Lankan male from a suburban region presented
with a two day history of fever. He complained of a mild headache
and epigastric discomfort but denied chest pain or palpitations. He
had no past medical history of note, and there was no family
history of ischemic heart disease or rhythm abnormalities. He was
on no regular medication and did not smoke or drink alcohol.
On admission, he had a pulse rate of 74 beats per minute (bpm)
and a blood pressure of 120/82 mmHg. Physical examination
revealed no abnormality, speciﬁcally, his heart sounds were* Corresponding author. Tel.: +65 81424187/91381115.
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4.0/).normal with no murmurs and there was no clinical evidence of
cardiac failure.
Initial investigations revealed a hemoglobin of 14.3 g/dl
reference range (RF) [11.0–16.5], Hematocrit 51.4% RF [36.0–
48.0], White Blood Cell count 6.1  109/L RF [4.0–11.0] and
platelets 162  109/L RF [150–400]. His serum potassium was
4.1 mmol/l RF [3.6–5.2], while magnesium and calcium levels were
within the normal range. His renal and liver functions were normal
and a 12 lead electrocardiogram (ECG) on admission (Fig. 1A)
revealed normal sinus rhythm at a rate of 70 bpm. Dengue IgG and
IgM antibodies were positive by immunochromatography and his
platelet count showed the expected fall to 40  109/L on day ﬁve of
fever, recovering to normal by day nine.
On the morning of his ﬁfth day of fever (third day of admission) he
was found to be bradycardic at a rate of 50 bpm and complained of
chest discomfort. His 12 lead ECG (Fig. 1B) revealed Mobitz type I A-V
block, there was no ST elevation or evidence of ischemia. The patient
was transferred to an intensive care unit and a temporary
transvenous pacing wire was inserted in anticipation of signiﬁcant
bradycardia with hemodynamic compromise. During the evening of
the same day his pulse rate dropped to 30 bpm, his blood pressure at
the time was 118/60 mmHg, he complained of mild chest discomfort
but was otherwise well. A two dimensional echocardiogram
revealed normal ventricular function and no wall motion abnor-
malities. Pacing was commenced at this stage (Fig. 1C) and he was
treated with intravenous methylprednisolone at a dose of 8 mg/kg
per day for 2 days. Assays for troponin T, creatine phosphokinase
(CPK) and myocardial bound CPK were all normal.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. (A) ECG on admission showing normal sinus rhythm. (B) ECG on day three showing Mobitz type I atrio-ventricular block. Blue arrows indicate the P waves. (C) ECG
showing a paced rhythm on day three. (D) ECG following discontinuation of pacing showing normal sinus rhythm.
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and we were able to remove his pacing wire after two days (ﬁfth
day of admission). He was transferred out of the intensive care unit
on day seven and made an uneventful recovery. A 12 lead ECG
(Fig. 1D) done after discontinuation of pacing revealed normal
sinus rhythm.
Discussion
The most common cardiac manifestation of dengue viral
infection is myocarditis, which is likely to occur with all four
serovars of dengue but may be more prevalent in DEN 3 infection
[1,2].
Myocardial inﬂammation is known to predispose to arrhyth-
mias and three mechanisms are thought to contribute. Firstly, the
inﬂammatory processes involving myocytes and the interstitium
can lead to alterations in membrane potential. Secondly, changes
in the parameters of ventricular dynamics such as increased wall
tension and myocardial oxygen consumption also increase the
potential for arrhythmias. Finally, ﬁbrosis and secondary atrophy
of myocytes can favor ectopic pacemaker development [3]. It is
likely that the former two mechanisms play the predominant role
in arrhythmias associated with dengue myocarditis which is an
acute, reversible condition.
A variety of arrhythmias have been reported in association with
dengue viral infection. Sinus bradycardia was shown to be
particularly prevalent during one outbreak in Singapore although
its use as a predictive factor for more malignant arrhythmias wasnot assessed [4]. In a series of 250 patients from Kerala (India),
16.8% had bradycardia. The majority of these were sinus
bradycardia while two patients were reported to have Mobitz
type 1 and 2 A-V block respectively [5]. Transient ventricular
ectopy and atrial ﬁbrillation have also been reported although
neither case was associated with hemodynamic compromise [6,7].
Mobitz type 1 A-V block in dengue viral infection has been
reported in children although the frequency of this complication in
the pediatric setting is uncertain [8]. The two children in question
were both in the recovery phase, their arrhythmias resolved
spontaneously and they did not require pacing. Mobitz type 1 A-V
block in adults has been reported in the acute and deferverscent
phases of dengue infection, spontaneous resolution of the A-V
block occurred in each case [5,9,10]. To the best of our knowledge,
ours is the ﬁrst report of such a patient developing symptomatic
bradycardia which required temporary pacing.
There is a paucity of randomized controlled trial evidence for
the use of intravenous corticosteroids in viral myocarditis. They
have, however, been shown to be effective in acute myocarditis of
other etiologies, in conjunction with intravenous immunoglobulin,
or cyclosporine with anti CD3 monoclonal antibody therapy
(muromonab) [11,12]. We therefore suggest that the use of
steroids as a therapeutic option in dengue myocarditis be further
evaluated by randomized controlled trials.
Our case also illustrates that Mobitz type 1 atrio-ventricular
block associated with dengue viral infection is a potentially life
threatening condition and close monitoring with consideration of
early pacing is warranted in these patients.
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